SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Long Term Provisions | ₹3.30 Cr | ₹2.69 Cr | ₹1.71 Cr | - | - |
What is the latest Long Term Provisions ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹3.30 Cr |
Mar2023 | ₹2.69 Cr |
Mar2022 | ₹1.71 Cr |
Mar2017 | - |
Mar2016 | - |
How is Long Term Provisions of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹3.30 Cr | 22.73 | |
Mar2023 | ₹2.69 Cr | 57.43 | |
Mar2022 | ₹1.71 Cr | 0 | |
Mar2017 | - | 0 | |
Mar2016 | - | - |
Compare Long Term Provisions of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,070.8 Cr | 5.8% | 34% | 85.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,068.0 Cr | 1.4% | 0.1% | 13.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,105.0 Cr | 0.8% | 12.3% | 47.2% | Stock Analytics | |
CIPLA | ₹122,016.0 Cr | 2.6% | -0.1% | 0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,651.0 Cr | 7.8% | 12.9% | 13.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,942.0 Cr | 2.7% | -0.6% | 14.4% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | 5.8% |
34% |
85.5% |
SENSEX | 2.1% |
3.7% |
14.3% |
You may also like the below Video Courses